Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

References

• Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., … Kuner, R. (2007). Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nature Neuroscience, 10(7), 870–879. doi:10.1038/nn1916
   PubMed Web of Science ®Google Scholar
• Ahluwalia, J., Urban, L., Capogna, M., Bevan, S., & Nagy, I. (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100(4), 685–688. doi:10.1016/S0306-4522(00)00389-4
   PubMed Web of Science ®Google Scholar
• Amaya, F., Shimosato, G., Kawasaki, Y., Hashimoto, S., Tanaka, Y., Ji, R. R., & Tanaka, M. (2006). Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain, 124(1–2), 175–183. doi:10.1016/j.pain.2006.04.001
   PubMed Web of Science ®Google Scholar
• Bajic, D., Monory, K., Conrad, A., Maul, C., Schmid, R. M., Wotjak, C. T., & Stein-Thoeringer, C. K. (2018). Cannabinoid receptor type 1 in the brain regulates the affective component of visceral pain in mice. Neuroscience, 384, 397–405. doi:10.1016/j.neuroscience.2018.05.041
   PubMed Web of Science ®Google Scholar
• Berghe, W. V., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G. (2003). A paradigm for gene regulation: Inflammation, NF-κB and PPAR. In F. Roels, M. Baes, & S. De Bie (Eds.), Peroxisomal disorders and regulation of genes (pp. 181–196). Boston, MA: Springer.
   Google Scholar
• Bishay, P., Haussler, A., Lim, H. Y., Oertel, B., Galve-Roperh, I., Ferreiros, N., & Tegeder, I. (2013). Anandamide deficiency and heightened neuropathic pain in aged mice. Neuropharmacology, 71, 204–215. doi:10.1016/j.neuropharm.2013.03.021
   PubMed Web of Science ®Google Scholar
• Calignano, A., La Rana, G., Giuffrida, A., & Piomelli, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature, 394(6690), 277–281. doi:10.1038/28393
   PubMed Web of Science ®Google Scholar
• Calvo, M., Dawes, J. M., & Bennett, D. L. (2012). The role of the immune system in the generation of neuropathic pain. The Lancet Neurology, 11(7), 629–642. doi:10.1016/S1474-4422(12)70134-5
   PubMed Web of Science ®Google Scholar
• Chen, L. H., Hedegaard, H., & Warner, M. (2014). Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS Data Brief, 166, 1–8.
   PubMedGoogle Scholar
• Clapper, J. R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., … Spradley, J. M. (2010). Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nature Neuroscience, 13(10), 1265–1270. doi:10.1038/nn.2632
   PubMed Web of Science ®Google Scholar
• Cooper, Z. D., Comer, S. D., & Haney, M. (2013). Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology, 38(10), 1984–1992. doi:10.1038/npp.2013.97
   PubMed Web of Science ®Google Scholar
• Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T. D., Bentley, H., & Gouaux, B. (2012). Smoked cannabis for spasticity in multiple sclerosis: A randomized, placebo-controlled trial. CMAJ, 184(10), 1143–1150. doi:10.1503/cmaj.110837
   PubMed Web of Science ®Google Scholar
• Dalton, G. D., Bass, C. E., Van Horn, C. G., & Howlett, A. C. (2009). Signal transduction via cannabinoid receptors. CNS & Neurological Disorders - Drug Targets, 8(6), 422–431.
   PubMed Web of Science ®Google Scholar
• de Novellis, V., Mariani, L., Palazzo, E., Vita, D., Marabese, I., Scafuro, M., … Maione, S. (2005). Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience, 134(1), 269–281. doi:10.1016/j.neuroscience.2005.03.014
   PubMed Web of Science ®Google Scholar
• Di Scala, G., Mana, M. J., Jacobs, W. J., & Phillips, A. G. (1987). Evidence of Pavlovian conditioned fear following electrical stimulation of the periaqueductal grey in the rat. Physiology & Behavior, 40(1), 55–63. doi:10.1016/0031-9384(87)90185-5
   PubMed Web of Science ®Google Scholar
• Dzau, V. J., & Pizzo, P. A. (2014). Relieving pain in America: Insights from an Institute of Medicine committee. JAMA, 312(15), 1507–1508. doi:10.1001/jama.2014.12986
   PubMed Web of Science ®Google Scholar
• Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., … Atkinson, J. H. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial. Neuropsychopharmacology, 34(3), 672–680. doi:10.1038/npp.2008.120
   PubMed Web of Science ®Google Scholar
• Finn, D. P., Jhaveri, M. D., Beckett, S. R., Roe, C. H., Kendall, D. A., Marsden, C. A., & Chapman, V. (2003). Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology, 45(5), 594–604. doi:10.1016/S0028-3908(03)00235-1
   PubMed Web of Science ®Google Scholar
• Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., … Wallace, M. (2015). Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurology, 14(2), 162–173. doi:10.1016/S1474-4422(14)70251-0
   PubMed Web of Science ®Google Scholar
• Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L., & James, I. (2001). The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92(1–2), 91–100. doi:10.1016/S0304-3959(00)00474-7
   PubMed Web of Science ®Google Scholar
• Freundt-Revilla, J., Kegler, K., Baumgärtner, W., & Tipold, A. (2017). Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system. PLoS ONE, 12(7), e0181064. doi:10.1371/journal.pone.0181064
   PubMed Web of Science ®Google Scholar
• Ghasemlou, N., Chiu, I. M., Julien, J. P., & Woolf, C. J. (2015). CD11b + Ly6G- myeloid cells mediate mechanical inflammatory pain hypersensitivity. Proceedings of the National Academy of Sciences of the United States of America, 112(49), E6808–E6817. doi:10.1073/pnas.1501372112
   PubMed Web of Science ®Google Scholar
• Gutierrez, T., Farthing, J. N., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2007). Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: A comparative analysis. British Journal of Pharmacology, 150(2), 153–163. doi:10.1038/sj.bjp.0706984
   PubMed Web of Science ®Google Scholar
• Hama, A. T., & Urban, M. O. (2004). Antihyperalgesic effect of the cannabinoid agonist WIN55, 212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats. Neuroscience Letters, 358(1), 21–24. doi:10.1016/j.neulet.2003.12.111
   PubMed Web of Science ®Google Scholar
• Harris, J., Drew, L. J., & Chapman, V. (2000). Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. NeuroReport, 11(12), 2817–2819. doi:10.1097/00001756-200008210-00041
   PubMed Web of Science ®Google Scholar
• Heinricher, M. M., Tavares, I., Leith, J. L., & Lumb, B. M. (2009). Descending control of nociception: Specificity, recruitment and plasticity. Brain Research Reviews, 60(1), 214–225. doi:10.1016/j.brainresrev.2008.12.009
   PubMedGoogle Scholar
• Herkendell, K., Tel-Vered, R., & Stemmer, A. (2017). Switchable aerobic/anaerobic multi-substrate biofuel cell operating on anodic and cathodic enzymatic cascade assemblies. Nanoscale, 9(37), 14118–14126. doi:10.1039/C7NR06233H
   PubMed Web of Science ®Google Scholar
• Hill, K. P., Palastro, M. D., Johnson, B., & Ditre, J. W. (2017). Cannabis and pain: A clinical review. Cannabis & Cannabinoid Research, 2(1), 96–104. doi:10.1089/can.2017.0017
   PubMedGoogle Scholar
• Hohmann, A. G., & Herkenham, M. (1999). Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience, 92(4), 1171–1175. doi:10.1016/S0306-4522(99)00220-1
   PubMed Web of Science ®Google Scholar
• Hohmann, A. G., Martin, W. J., Tsou, K., & Walker, J. M. (1995). Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sciences, 56(23–24), 2111–2118. doi:10.1016/0024-3205(95)00196-D
   PubMed Web of Science ®Google Scholar
• Hudson, R., & Puvanenthirarajah, N. (2018). Cannabis for pain management: Pariah or panacea? University of Western Ontario Medical Journal, 87(1), 58–61. doi:10.5206/uwomj.v87i1.1922
   Google Scholar
• Ignatowska-Jankowska, B. M., Baillie, G. L., Kinsey, S., Crowe, M., Ghosh, S., Owens, R. A., … Zanda, M. (2015). A cannabinoid CB 1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects. Neuropsychopharmacology, 40(13), 2948–2959. doi:10.1038/npp.2015.148
   PubMed Web of Science ®Google Scholar
• Ji, R.-R., Chamessian, A., & Zhang, Y.-Q. (2016). Pain regulation by non-neuronal cells and inflammation. Science, 354(6312), 572–577. doi:10.1126/science.aaf8924
   PubMed Web of Science ®Google Scholar
• Kalliomaki, J., Annas, P., Huizar, K., Clarke, C., Zettergren, A., Karlsten, R., & Segerdahl, M. (2013). Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia. Clinical & Experimental Pharmacology & Physiology, 40(3), 212–218. doi:10.1111/1440-1681.12051
   PubMed Web of Science ®Google Scholar
• Katona, I., & Freund, T. F. (2008). Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nature Medicine, 14(9), 923–930. doi:10.1038/nm.f.1869
   PubMed Web of Science ®Google Scholar
• Katona, I., Rancz, E. A., Acsady, L., Ledent, C., Mackie, K., Hajos, N., & Freund, T. F. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. Journal of Neuroscience, 21(23), 9506–9518. doi:10.1523/JNEUROSCI.21-23-09506.2001
   PubMed Web of Science ®Google Scholar
• Khasabova, I. A., Holman, M., Morse, T., Burlakova, N., Coicou, L., Harding-Rose, C., … Seybold, V. S. (2013). Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiology of Disease, 58, 19–28. doi:10.1016/j.nbd.2013.04.018
   PubMed Web of Science ®Google Scholar
• Kim, E. J., Horovitz, O., Pellman, B. A., Tan, L. M., Li, Q., Richter-Levin, G., & Kim, J. J. (2013). Dorsal periaqueductal gray-amygdala pathway conveys both innate and learned fear responses in rats. Proceedings of the National Academy of Sciences of the United States of America, 110(36), 14795–14800. doi:10.1073/pnas.1310845110
   PubMed Web of Science ®Google Scholar
• Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., … Evans, R. M. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences of the United States of America, 91(15), 7355–7359. doi:10.1073/pnas.91.15.7355
   PubMed Web of Science ®Google Scholar
• Koch, S. C., & Fitzgerald, M. (2014). The selectivity of rostroventral medulla descending control of spinal sensory inputs shifts postnatally from A fibre to C fibre evoked activity. Journal of Physiology, 592(7), 1535–1544. doi:10.1113/jphysiol.2013.267518
   PubMed Web of Science ®Google Scholar
• Kunos, G., Osei-Hyiaman, D., Bátkai, S., Sharkey, K. A., & Makriyannis, A. (2009). Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain? Trends in Pharmacological Sciences, 30(1), 1–7. doi:10.1016/j.tips.2008.10.001
   PubMed Web of Science ®Google Scholar
• Kunos, G., & Tam, J. (2011). The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. British Journal of Pharmacology, 163(7), 1423–1431. doi:10.1111/j.1476-5381.2011.01352.x
   PubMed Web of Science ®Google Scholar
• La Porta, C., Bura, S. A., Llorente-Onaindia, J., Pastor, A., Navarrete, F., Garcia-Gutierrez, M. S., … Maldonado, R. (2015). Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. Pain, 156(10), 2001–2012. doi:10.1097/j.pain.0000000000000260
   PubMed Web of Science ®Google Scholar
• Liu, J., Li, H., Burstein, S. H., Zurier, R. B., & Chen, J. D. (2003). Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Molecular Pharmacology, 63(5), 983–992. doi:10.1124/mol.63.5.983
   PubMed Web of Science ®Google Scholar
• Mackie, K. (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook of Experimental Pharmacology, 168, 299–325. doi:10.1007/3-540-26573-2_10
   PubMedGoogle Scholar
• Martin, W. J., Coffin, P. O., Attias, E., Balinsky, M., Tsou, K., & Walker, J. M. (1999). Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Research, 822(1–2), 237–242. doi:10.1016/S0006-8993(98)01368-7
   PubMed Web of Science ®Google Scholar
• Martin, W. J., Patrick, S. L., Coffin, P. O., Tsou, K., & Walker, J. M. (1995). An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sciences, 56(23–24), 2103–2109. doi:10.1016/0024-3205(95)00195-C
   PubMed Web of Science ®Google Scholar
• Martin, W. J., Tsou, K., & Walker, J. M. (1998). Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neuroscience Letters, 242(1), 33–36. doi:10.1016/S0304-3940(98)00044-5
   PubMed Web of Science ®Google Scholar
• McAllister, S. D., Griffin, G., Satin, L. S., & Abood, M. E. (1999). Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. The Journal of Pharmacology & Experimental Therapeutics, 291(2), 618–626.
   PubMed Web of Science ®Google Scholar
• Meng, I. D., & Johansen, J. P. (2004). Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist. Neuroscience, 124(3), 685–693. doi:10.1016/j.neuroscience.2003.10.001
   PubMed Web of Science ®Google Scholar
• Millns, P. J., Chapman, V., & Kendall, D. A. (2001). Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. British Journal of Pharmacology, 132(5), 969–971. doi:10.1038/sj.bjp.0703919
   PubMed Web of Science ®Google Scholar
• Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., … Spigelman, I. (2006). Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain, 126(1–3), 102–114. doi:10.1016/j.pain.2006.06.016
   PubMed Web of Science ®Google Scholar
• Murphy, T. D., Weidenbach, K. N., Van Houten, C., Gerona, R. R., Moran, J. H., Kirschner, R. I., … Newman, A. (2013). Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. Morbidity and Mortality Weekly Report, 62(6), 93.
   PubMed Web of Science ®Google Scholar
• Nackley, A. G., Suplita, R. L., 2nd, & Hohmann, A. G. (2003). A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience, 117(3), 659–670. doi:10.1016/S0306-4522(02)00870-9
   PubMed Web of Science ®Google Scholar
• Naderi, N., Shafaghi, B., Khodayar, M.-J., & Zarindast, M.-R. (2005). Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat. European Journal of Pharmacology, 514(2–3), 159–164. doi:10.1016/j.ejphar.2005.03.037
   PubMed Web of Science ®Google Scholar
• Pacher, P., & Kunos, G. (2013). Modulating the endocannabinoid system in human health and disease–successes and failures. FEBS Journal, 280(9), 1918–1943. doi:10.1111/febs.12260
   PubMed Web of Science ®Google Scholar
• Palazzo, E., Luongo, L., Novellis, V., Rossi, F., & Maione, S. (2010). The role of cannabinoid receptors in the descending modulation of pain. Pharmaceuticals, 3(8), 2661–2673. doi:10.3390/ph3082661
   Google Scholar
• Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006). Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology & Drug Safety, 15(9), 618–627. doi:10.1002/pds.1276
   PubMed Web of Science ®Google Scholar
• Pertwee, R. G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacology & Therapeutics, 74(2), 129–180. doi:10.1016/S0163-7258(97)82001-3
   PubMed Web of Science ®Google Scholar
• Racz, I., Nent, E., Erxlebe, E., & Zimmer, A. (2015). CB1 receptors modulate affective behaviour induced by neuropathic pain. Brain Research Bulletin, 114, 42–48. doi:10.1016/j.brainresbull.2015.03.005
   PubMed Web of Science ®Google Scholar
• Rea, K., Roche, M., & Finn, D. P. (2007). Supraspinal modulation of pain by cannabinoids: The role of GABA and glutamate. British Journal of Pharmacology, 152(5), 633–648. doi:10.1038/sj.bjp.0707440
   PubMed Web of Science ®Google Scholar
• Rezayof, A., Sardari, M., Zarrindast, M. R., & Nayer-Nouri, T. (2011). Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behavioral Brain Research, 220(1), 1–8. doi:10.1016/j.bbr.2011.01.023
   PubMed Web of Science ®Google Scholar
• Richardson, J. D., Kilo, S., & Hargreaves, K. M. (1998). Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain, 75(1), 111–119. doi:10.1016/S0304-3959(97)00213-3
   PubMed Web of Science ®Google Scholar
• Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005). Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology, 65(6), 812–819. doi:10.1212/01.wnl.0000176753.45410.8b
   PubMed Web of Science ®Google Scholar
• Seltzman, H. H., Shiner, C., Hirt, E. E., Gilliam, A. F., Thomas, B. F., Maitra, R., … Spigelman, I. (2016). Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain. Journal of Medicinal Chemistry, 59(16), 7525–7543. doi:10.1021/acs.jmedchem.6b00516
   PubMed Web of Science ®Google Scholar
• Sideris, A., Piskoun, B., Russo, L., Norcini, M., Blanck, T., Recio-Pinto, E. (2016). Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity. Molecular Pain, 12, 1744806916649191. doi:10.1177/1744806916649191
   Google Scholar
• Skaper, S. D., & Di Marzo, V. (2012). Endocannabinoids in nervous system health and disease: The big picture in a nutshell. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1607), 3193–3200. doi:10.1098/rstb.2012.0313
   PubMed Web of Science ®Google Scholar
• Stander, S., Schmelz, M., Metze, D., Luger, T., & Rukwied, R. (2005). Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. Journal of Dermatological Science, 38(3), 177–188. doi:10.1016/j.jdermsci.2005.01.007
   PubMed Web of Science ®Google Scholar
• Sugamura, K., Sugiyama, S., Nozaki, T., Matsuzawa, Y., Izumiya, Y., Nakayama, M., … Ogawa, H. (2009). Activated endocannabinoid system in coronary artery disease and anti-inflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation, 119, 28–36.
   PubMed Web of Science ®Google Scholar
• Vaughan, C. W., & Christie, M. J. (2005). Retrograde signalling by endocannabinoids. In R. E. Pertwee (Eds), Handbook of experimental pharmacology (pp. 367–383). Berlin, Heidelberg: Springer.
   Google Scholar
• Vaughan, C. W., Connor, M., Bagley, E. E., & Christie, M. J. (2000). Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Molecular Pharmacology, 57(2), 288–295.
   PubMed Web of Science ®Google Scholar
• Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sanudo-Pena, M. C. (1999). Pain modulation by release of the endogenous cannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America, 96(21), 12198–12203. doi:10.1073/pnas.96.21.12198
   PubMed Web of Science ®Google Scholar
• Wallace, M. S., Marcotte, T. D., Umlauf, A., Gouaux, B., & Atkinson, J. H. (2015). Efficacy of inhaled cannabis on painful diabetic neuropathy. Journal of Pain, 16(7), 616–627. doi:10.1016/j.jpain.2015.03.008
   PubMed Web of Science ®Google Scholar
• Wang, H., Liu, W., Cai, Y., Ma, L., Ma, C., Luo, A., & Huang, Y. (2016). Glutaminase 1 is a potential biomarker for chronic post-surgical pain in the rat dorsal spinal cord using differential proteomics. Amino Acids, 48(2), 337–348. doi:10.1007/s00726-015-2085-z
   PubMed Web of Science ®Google Scholar
• Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., … Collet, J. P. (2010). Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. CMAJ, 182(14), E694–E701. doi:10.1503/cmaj.091414
   PubMed Web of Science ®Google Scholar
• Webster, L. R., Cochella, S., Dasgupta, N., Fakata, K. L., Fine, P. G., Fishman, S. M., … Wakeland, W. (2011). An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Medicine, 12(2), S26–S35. doi:10.1111/j.1526-4637.2011.01134.x
   PubMed Web of Science ®Google Scholar
• Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H. (2013). Low-dose vaporized cannabis significantly improves neuropathic pain. Journal of Pain, 14(2), 136–148. doi:10.1016/j.jpain.2012.10.009
   PubMed Web of Science ®Google Scholar
• Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S. (2008). A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. Journal of Pain, 9(6), 506–521. doi:10.1016/j.jpain.2007.12.010
   PubMed Web of Science ®Google Scholar
• Woolf, C. J. (2013). Pain: Morphine, metabolites, mambas, and mutations. Lancet Neurology, 12(1), 18–20. doi:10.1016/S1474-4422(12)70287-9
   PubMed Web of Science ®Google Scholar